2016 -- H 7710 SUBSTITUTE A

========

LC004903/SUB A

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2016

____________

A N   A C T

RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES

     

     Introduced By: Representatives Bennett, Hull, McNamara, Azzinaro, and Diaz

     Date Introduced: February 24, 2016

     Referred To: House Corporations

     It is enacted by the General Assembly as follows:

1

     SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness

2

Insurance Policies" is hereby amended by adding thereto the following section:

3

     27-18-82. Opioid antagonists. -- (a) Every individual or group health insurance contract,

4

plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended

5

or renewed in this state on or after January 1, 2017, shall provide coverage for at least one generic

6

opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid

7

antagonists and devices.

8

     (b) As used in this section:

9

     "Opioid antagonist" means naloxone hydrochloride and any other drug approved by the

10

United States Food and Drug Administration for the treatment of opioid overdose.

11

     (c) The coverage mandated by this section shall include generic opioid antagonists

12

prescribed or dispensed via standing order or collaborative practice agreement intended for use on

13

patients other than the insured. Prior authorization may be required for non-generic forms of

14

opioid antagonists and devices.

15

     (d) Notwithstanding ยง27-18-19 or any other provision to the contrary, this section shall

16

apply to blanket or group polices of insurance.

17

     SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service

18

Corporations" is hereby amended by adding thereto the following section:

19

     27-19-73. Opioid antagonists. -- (a) Every individual or group health insurance contract,

 

1

plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended

2

or renewed in this state on or after January 1, 2017, shall provide coverage for at least one generic

3

opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid

4

antagonists and devices.

5

     (b) As used in this section:

6

     "Opioid antagonist" means naloxone hydrochloride and any other drug approved by the

7

United States Food and Drug Administration for the treatment of opioid overdose.

8

     (c) The coverage mandated by this section shall include generic opioid antagonists

9

prescribed or dispensed via standing order or collaborative practice agreement intended for use on

10

patients other than the insured. Prior authorization may be required for non-generic forms of

11

opioid antagonists and devices.

12

     SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service

13

Corporations" is hereby amended by adding thereto the following section:

14

     27-20-69. Opioid antagonists. -- (a) Every individual or group health insurance contract,

15

plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended

16

or renewed in this state on or after January 1, 2017, shall provide coverage for at least one generic

17

opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid

18

antagonists and devices.

19

     (b) As used in this section:

20

     "Opioid antagonist" means naloxone hydrochloride and any other drug approved by the

21

United States Food and Drug Administration for the treatment of opioid overdose.

22

     (c) The coverage mandated by this section shall include generic opioid antagonists

23

prescribed or dispensed via standing order or collaborative practice agreement intended for use on

24

patients other than the insured. Prior authorization may be required for non-generic forms of

25

opioid antagonists and devices.

26

     SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance

27

Organizations" is hereby amended by adding thereto the following section:

28

     27-41-86. Opioid antagonists. -- (a) Every individual or group health insurance contract,

29

plan, or policy that provides prescription coverage that is delivered, issued for delivery, amended

30

or renewed in this state on or after January 1, 2017, shall provide coverage for at least one generic

31

opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid

32

antagonists and devices.

33

     (b) As used in this section:

34

     "Opioid antagonist" means naloxone hydrochloride and any other drug approved by the

 

LC004903/SUB A - Page 2 of 4

1

United States Food and Drug Administration for the treatment of opioid overdose.

2

     (c) The coverage mandated by this section shall include generic opioid antagonists

3

prescribed or dispensed via standing order or collaborative practice agreement intended for use on

4

patients other than the insured. Prior authorization may be required for non-generic forms of

5

opioid antagonists and devices.

6

     SECTION 5. This act shall take effect on January 1, 2017.

========

LC004903/SUB A

========

 

LC004903/SUB A - Page 3 of 4

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES

***

1

     This act would require all health insurance providers that provide prescription coverage

2

to include coverage for generic opioid antagonists (overdose preventive medicine), and devices. It

3

would permit prior authorization for non-generic forms of opioid antagonists and devices. This

4

act would apply to nonprofit hospital service corporations, nonprofit medical service corporations

5

and health maintenance organizations.

6

     This act would take effect on January 1, 2017.

========

LC004903/SUB A

========

 

LC004903/SUB A - Page 4 of 4